Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Multierosive Juvenile Idiopathic Arthritis With Positive Rheumatoid Factor: A Case Report of a Young Girl Followed at the University Clinics of Bukavu.

Created on 28 Jul 2026

Authors

Delphin Murhula Katabana, Théophile Barhwamire Kabesha, Rodrigue Mupenda Mwenibamba, Roland Lwandiko Cibenda, Paul Ngongo Tshonda, Archippe Birindwa Muhandule, Philippe Katchunga Bianga, Tony Shindano Akilimali

Published in

Case reports in rheumatology. Volume 2026. Pages 9884531. Epub Jul 26, 2026.

Abstract

Polyarticular juvenile idiopathic arthritis (JIA) with positive rheumatoid factor is a rare and severe form of chronic inflammatory rheumatism in children. We report the case of a young girl treated at the University Clinics of Bukavu (eastern DR Congo), whose disease began at the age of 10. The course of the disease was characterized by highly inflammatory polyarthritis with severe multierosive lesions. Immunological testing revealed positivity for rheumatoid factor and anti-CCP antibodies. Diagnosis and treatment were delayed for approximately nine years (2008-2017). Management was complicated by poor adherence and discontinuation of methotrexate and corticosteroids. The patient subsequently died to recurrent infectious complications and hypertension. This case illustrates the impact of diagnostic delay and difficulties in accessing care on the prognosis of severe forms of JIA in resource-limited settings.

PMID:
42516937
Bibliographic data and abstract were imported from PubMed on 28 Jul 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 6
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement